2013. ISPOR European Congress – What are the Key Drivers of Reimbursement for Biosimilars? An Explanation of Reimbursement Process and Recommendations across Nine Countries

de Silva SU, Smith TA, Bending MW. What are the Key Drivers of Reimbursement for Biosimilars? An Explanation of Reimbursement Process and Recommendations across Nine Countries. Value Health. 2013 Nov;16(7):A323. Presented at: ISPOR 16th Annual European Congress; November 4, 2013; Dublin, Ireland.